The DTRF advocates for almost a decade for clinical trials in the promising desmoid tumor treatment nirogacestat. After a successful Phase 3 trial, Springworks Therapeutics files a new drug application. If approved by the FDA, this will be the first drug approved in desmoid tumors! The trial is published in the NEJM.
Stay Up to Date as We Uncover More About Desmoid Tumors
Your Donation Changes Lives
Every donation, no matter the size, helps us continue our mission.
